FDA Inspection 1224641 — Begona Perez Valderrama, M.D.
The FDA completed an inspection of Begona Perez Valderrama, M.D. on Nov 16, 2023 in Sevilla. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sevilla (Spain)
Additional Details
Clinical Investigator (CI)